Table 1.
Demographic and Virologic Characteristics for 145 Patientsa
| Characteristic | Value |
| Sex | |
| Male | 84 (58) |
| Female | 61 (42) |
| Mean age, years | 40.7 |
| Age, years | |
| <21 | 14 (10) |
| ≥21 | 131 (90) |
| Myeloablative conditioning | 145 (100) |
| Donor type | |
| Matched related | 49 (34) |
| Mismatched related | 9 (6) |
| Unrelated | 62 (43) |
| Autologous | 25 (17) |
| Deaths before day 100 | 37 (26) |
| Plasma samples tested, no. | 1084 |
| Samples per patient, median (range) | 8 (1–18) |
| AAV-positive specimens, no. | 6 |
| AAV-positive patients, no. (%) | 4 (2.8) |
| Duration between transplant and AAV detection, mean (range), days | 47.5 (21–77) |
| Duration of viral detection, median (range), wk | 1 (1–3) |
| Viral load, mean (range), copies/mL, | 753 (50–2571) |
Abbreviation: AAV, adeno-associated virus.
a
Unless otherwise indicated, values represent no. (%) of patients.